A functional assay suggested that the genetic variation rs16917496 in the miR-502 binding site could modify NSCLC outcome through regulating the expression of SET8. The findings further highlight that polymorphisms in miRNA-binding sites may play an important role in lung cancer and may have an effect on patients’ clinical outcome. This evidence concerns the gene KMT5A and lung carcinoma.